You have 9 free searches left this month | for more free features.

Monoclonal

Showing 1 - 25 of 8,846

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Project in First-degree Relatives of Myeloma Patient - The

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Sample of Blood
  • Shanghai, Shanghai, China
    Zhongshan Hospital,Fudan University
Jul 31, 2023

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting
  • NSCLC Stage IV
  • (no location specified)
Mar 15, 2023

Bevacizumab Combined With PD-1 Monoclonal Antibody in

Not yet recruiting
  • Colorectal Cancer
  • Bevacizumab Combined With PD-1 Monoclonal Antibody
  • (no location specified)
Nov 8, 2023

Rectal Cancer Trial (Short-course radiotherapy combined with furoquintinib and PD-1 mAb)

Not yet recruiting
  • Rectal Cancer
  • Short-course radiotherapy combined with furoquintinib and PD-1 monoclonal antibody
  • (no location specified)
Aug 29, 2023

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Quality of Life in Asymptomatic Monoclonal Gammopathies

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Plasma Cell Myeloma
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Antibody-mediated Rejection, Kidney Tranplant Trial in Hangzhou (Daratumumab)

Not yet recruiting
  • Antibody-mediated Rejection
  • Kidney Tranplant
  • Hangzhou, Zhejiang, China
    79# Qingchun Road
Jun 21, 2023

Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

Not yet recruiting
  • Multiple Cancer
  • Colorectal Cancer
  • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
  • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
  • (no location specified)
Aug 20, 2023

Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)

Not yet recruiting
  • Proliferative Glomerulonephritis With Monoclonal IgG Deposits
  • Rochester, Minnesota
    Mayo Clinic Minnesota
Dec 8, 2022

Monoclonal Gammopathy Trial in New York, Philadelphia (Isatuximab)

Recruiting
  • Monoclonal Gammopathy
  • Boston, Massachusetts
  • +1 more
Nov 16, 2022

Advanced Solid Tumor Trial in Bengbu (HB0030 injection)

Recruiting
  • Advanced Solid Tumor
  • HB0030 injection
  • Bengbu, Anhui, China
    the First Affiliated Hospital of Bengbu Medical College
Jan 20, 2023

Assess New Participant's Perspectives Beyond Clinical Efficacy

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
    • (no location specified)
    Nov 7, 2023

    Acquired Hemophilia Trial in Tianjin (Daratumumab)

    Recruiting
    • Acquired Hemophilia
    • Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    May 5, 2023

    Atopic Dermatitis Trial in Shanghai (MG-K10/Placebo)

    Active, not recruiting
    • Atopic Dermatitis
    • MG-K10/Placebo
    • Shanghai, China
      Huashan Hospital Affiliated to Fudan University
    Aug 31, 2023

    HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

    Completed
    • HER2 Positive Breast Carcinoma
    • +6 more
    • Palo Alto, California
      Stanford University, School of Medicine
    Sep 22, 2022

    Ovarian Cancer Trial in New York (Monoclonal antibody hu3S193)

    Terminated
    • Ovarian Cancer
    • Monoclonal antibody hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

    Not yet recruiting
    • MSS
    • Rectal Cancer
    • Sintilimab with Interleukin-2
    • (no location specified)
    Nov 1, 2023

    Acute Gout Trial in Wuhan, Linyi, Shanghai (Recombinant Anti-IL-1ß Humanized Monoclonal Antibody Injection 100 mg (phase Ib),

    Recruiting
    • Acute Gout
    • Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg (phase Ib)
    • +6 more
    • Wuhan, Hubei, China
    • +2 more
    Oct 17, 2022

    Ovarian Cancer Trial in New York (90Y-hu3S193, 111In-hu3S193)

    Completed
    • Ovarian Cancer
    • 90Y-hu3S193
    • 111In-hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Lymphoma, T-Cell
    • Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
    • Najing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Sep 26, 2022

    Diabetic Polyneuropathy Trial in Rochester, Aarhus, Copenhagen (Eptinezumab, Placebo)

    Not yet recruiting
    • Diabetic Polyneuropathy
    • Rochester, Minnesota
    • +2 more
    Jun 30, 2023

    Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma Trial in Changchun (Rituximab,

    Recruiting
    • Peripheral T-Cell Lymphoma, Not Otherwise Specified
    • Angioimmunoblastic T-cell Lymphoma
    • Changchun, Jilin, China
      The First Bethune Hospital of Jilin University
    Apr 7, 2023

    Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance Trial in Washington (Daratumumab and

    Not yet recruiting
    • Peripheral Neuropathy
    • Monoclonal Gammopathy of Undetermined Significance
    • Daratumumab and hyaluronidase-fihj
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Sep 14, 2023

    Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment

    Recruiting
    • COVID-19 Convalescent Plasma Treatment
      • Strasbourg, France
        Service des Maladies Infectieuses et Tropicales - CHU de Strasbo
      Jun 15, 2023